All filters
Slidesets
Appropriate Use of Hormonal Replacement Therapy During Menopause.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Case Series of Women With HIV Who Breastfed.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Cardiovascular Risk for Women - Data from the Reprieve Study.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
EmpowerHER Black Women's Reasons for HIV Prevention.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Comorbidities in Trans Women.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Infant Feeding Choices for Parents Living With HIV Updates From the INFORM+ Forum Group.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Metabolic Complications - The Role of the New Weight Reduction Therapies.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Overview of Cardiovascular Diseases in Women.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Service Delivery for Women Aging with HIV.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
The CD38-NAD+ Axis Mediates a Hyperinflammatory State in WLWH.pdf
Presented at:
International Workshop on HIV & Women 2024
Slidesets
Update on Use of Antiretrovirals in Pregnancy.pdf
Presented at:
International Workshop on HIV & Women 2024
Meeting
Innovations in SLD Think-Tank 2025
Spain
In-Person Meeting
Slidesets
Management of Toxicities from Immunotherapy: an ESMO Clinical Practice Guideline | Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Therapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic? | Markus Jörger, MD, PhD, ClinPharm
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. | Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Meeting
International Workshop on Women & HIV 2025
11 Apr 2025 - 12 Apr 2025
Spain
Hybrid Meeting